Literature DB >> 18582979

In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol.

Jun-ichi Jinno1, Naoki Kamada, Masateru Miyake, Keigo Yamada, Tadashi Mukai, Masaaki Odomi, Hajime Toguchi, Gary G Liversidge, Kazutaka Higaki, Toshikiro Kimura.   

Abstract

The purpose of the present study was to investigate oral bioavailability of an immediate release tablet containing wet-milled crystals of a poorly water-soluble drug, cilostazol, and to establish in vitro-in vivo correlation. Sub-micron sized cilostazol (median diameter: 0.26 microm) was successfully prepared using a beads-mill in water in the presence of a hydrophilic polymer and an anionic surfactant. The milled suspension was solidified with a sugar alcohol as a water-soluble carrier by spray-drying method. The co-precipitate was compressed into an immediate release tablet with common excipients. Oral bioavailability of the wet-milled cilostazol tablet in male beagle dogs was 13-fold higher than the hammer-milled commercial tablet in fasted condition. Food did not increase the oral bioavailability of the wet-milled tablet, while 4-fold increase was found for the commercial tablet. Irrespective to the bioavailability enhancement, in vitro dissolution rate of the wet-milled tablet was even slower than the commercial tablet by the compendial method (USP Apparatus 2). On the other hand, a good correlation was found between the dissolution profiles obtained by a flow-through cell method (USP Apparatus 4, closed-loop system without outlet filter) using a large volume of water and sodium lauryl sulfate (SLS) solution at the concentration lower than the critical micellar concentration (cmc) as dissolution media corresponding to the fasted and fed conditions, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582979     DOI: 10.1016/j.jconrel.2008.05.013

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

1.  Development of a new method to assess nanocrystal dissolution based on light scattering.

Authors:  Katharina Anhalt; Simon Geissler; Meike Harms; Markus Weigandt; Gert Fricker
Journal:  Pharm Res       Date:  2012-06-12       Impact factor: 4.200

2.  A systematic approach to design and prepare solid dispersions of poorly water-soluble drug.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

3.  CLSM as quantitative method to determine the size of drug crystals in a solid dispersion.

Authors:  Hans de Waard; Martin J T Hessels; Maarten Boon; Klaas A Sjollema; Wouter L J Hinrichs; Anko C Eissens; Henderik W Frijlink
Journal:  Pharm Res       Date:  2011-05-24       Impact factor: 4.200

4.  NanoClusters surface area allows nanoparticle dissolution with microparticle properties.

Authors:  Christopher Kuehl; Nashwa El-Gendy; Cory Berkland
Journal:  J Pharm Sci       Date:  2014-04-30       Impact factor: 3.534

5.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

6.  Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2015-02-12       Impact factor: 3.246

7.  Enhanced percutaneous absorption of cilostazol nanocrystals using aqueous gel patch systems and clarification of the absorption mechanism.

Authors:  Chiaki Yoshioka; Yoshimasa Ito; Noriaki Nagai
Journal:  Exp Ther Med       Date:  2018-01-31       Impact factor: 2.447

8.  An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats.

Authors:  Chiaki Yoshioka; Yoshimasa Ito; Noriaki Nagai
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

9.  Comparative in vitro dissolution study of carbamazepine immediate-release products using the USP paddles method and the flow-through cell system.

Authors:  José Raúl Medina; Dulce Karina Salazar; Marcela Hurtado; Alma Rosa Cortés; Adriana Miriam Domínguez-Ramírez
Journal:  Saudi Pharm J       Date:  2013-02-11       Impact factor: 4.330

10.  In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.

Authors:  Xia Cao; Wen-Wen Deng; Min Fu; Liang Wang; Shan-Shan Tong; Ya-Wei Wei; Ying Xu; Wei-Yan Su; Xi-Ming Xu; Jiang-Nan Yu
Journal:  Int J Nanomedicine       Date:  2012-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.